ArticleJournal of thrombosis and thrombolysis2026

Efficacy and safety of low-dose tirofiban plus dual antiplatelet therapy in acute cerebral infarction beyond the thrombolysis window: a non-randomized trial with preliminary findings.

Jing Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.